Correlation Between Genelux Common and Ascletis Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genelux Common and Ascletis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genelux Common and Ascletis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genelux Common and Ascletis Pharma, you can compare the effects of market volatilities on Genelux Common and Ascletis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genelux Common with a short position of Ascletis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genelux Common and Ascletis Pharma.

Diversification Opportunities for Genelux Common and Ascletis Pharma

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Genelux and Ascletis is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Genelux Common and Ascletis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascletis Pharma and Genelux Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genelux Common are associated (or correlated) with Ascletis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascletis Pharma has no effect on the direction of Genelux Common i.e., Genelux Common and Ascletis Pharma go up and down completely randomly.

Pair Corralation between Genelux Common and Ascletis Pharma

Given the investment horizon of 90 days Genelux Common is expected to under-perform the Ascletis Pharma. In addition to that, Genelux Common is 1.06 times more volatile than Ascletis Pharma. It trades about -0.08 of its total potential returns per unit of risk. Ascletis Pharma is currently generating about 0.12 per unit of volatility. If you would invest  16.00  in Ascletis Pharma on August 28, 2024 and sell it today you would earn a total of  2.00  from holding Ascletis Pharma or generate 12.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Genelux Common  vs.  Ascletis Pharma

 Performance 
       Timeline  
Genelux Common 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Genelux Common are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Genelux Common showed solid returns over the last few months and may actually be approaching a breakup point.
Ascletis Pharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ascletis Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Ascletis Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Genelux Common and Ascletis Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genelux Common and Ascletis Pharma

The main advantage of trading using opposite Genelux Common and Ascletis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genelux Common position performs unexpectedly, Ascletis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascletis Pharma will offset losses from the drop in Ascletis Pharma's long position.
The idea behind Genelux Common and Ascletis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments